DE60006976D1 - Verfahren zur herstellung von sphärische telithromycin-agglomerate sowie deren verwendung zur vorbereitung von arzneiformen - Google Patents

Verfahren zur herstellung von sphärische telithromycin-agglomerate sowie deren verwendung zur vorbereitung von arzneiformen

Info

Publication number
DE60006976D1
DE60006976D1 DE60006976T DE60006976T DE60006976D1 DE 60006976 D1 DE60006976 D1 DE 60006976D1 DE 60006976 T DE60006976 T DE 60006976T DE 60006976 T DE60006976 T DE 60006976T DE 60006976 D1 DE60006976 D1 DE 60006976D1
Authority
DE
Germany
Prior art keywords
producing spherical
medicinal forms
preparing medicinal
agglomerates
spherical telithromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006976T
Other languages
English (en)
Other versions
DE60006976T2 (de
Inventor
Jean-Yves Godard
Valerie Rognon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60006976(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE60006976D1 publication Critical patent/DE60006976D1/de
Application granted granted Critical
Publication of DE60006976T2 publication Critical patent/DE60006976T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE60006976T 1999-08-26 2000-08-28 Verfahren zur herstellung von sphärische telithromycin-agglomerate sowie deren verwendung zur vorbereitung von arzneiformen Expired - Lifetime DE60006976T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (2)

Publication Number Publication Date
DE60006976D1 true DE60006976D1 (de) 2004-01-15
DE60006976T2 DE60006976T2 (de) 2004-10-21

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006976T Expired - Lifetime DE60006976T2 (de) 1999-08-26 2000-08-28 Verfahren zur herstellung von sphärische telithromycin-agglomerate sowie deren verwendung zur vorbereitung von arzneiformen

Country Status (34)

Country Link
US (1) US6825218B1 (de)
EP (1) EP1212336B1 (de)
JP (1) JP4871467B2 (de)
KR (1) KR100718222B1 (de)
CN (1) CN1183151C (de)
AR (1) AR025398A1 (de)
AT (1) ATE255590T1 (de)
AU (1) AU774385B2 (de)
BR (1) BR0013569B1 (de)
CA (1) CA2382497C (de)
CO (1) CO5190666A1 (de)
CZ (1) CZ2002594A3 (de)
DE (1) DE60006976T2 (de)
DK (1) DK1212336T3 (de)
EA (1) EA005080B1 (de)
ES (1) ES2209970T3 (de)
FR (1) FR2797875B1 (de)
HK (1) HK1049167B (de)
HR (1) HRP20020167B1 (de)
HU (1) HU229075B1 (de)
IL (2) IL148128A0 (de)
ME (2) MEP20108A (de)
MX (1) MXPA02001988A (de)
NO (1) NO322622B1 (de)
PL (1) PL204100B1 (de)
PT (1) PT1212336E (de)
RS (1) RS50433B (de)
SI (1) SI1212336T1 (de)
SK (1) SK287588B6 (de)
TR (1) TR200200506T2 (de)
TW (1) TWI272949B (de)
UA (1) UA73523C2 (de)
WO (1) WO2001014393A2 (de)
ZA (1) ZA200201599B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
CA2492874C (en) * 2002-07-19 2011-09-20 Aventis Pharma S.A. Taste masked oral composition of telithromycin
SI1610878T1 (sl) * 2003-02-21 2015-02-27 University Of Bath Postopek za proizvodnjo delcev
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (de) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Herstellung von feinen Materialien
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
FR2797875A1 (fr) 2001-03-02
HRP20020167B1 (en) 2006-06-30
AR025398A1 (es) 2002-11-27
ME00112B (me) 2010-10-10
DK1212336T3 (da) 2004-03-15
EP1212336A2 (de) 2002-06-12
BR0013569A (pt) 2002-05-14
PL204100B1 (pl) 2009-12-31
HK1049167A1 (en) 2003-05-02
YU13202A (sh) 2004-09-03
NO20020926L (no) 2002-02-26
AU7018100A (en) 2001-03-19
CA2382497C (fr) 2011-06-28
CO5190666A1 (es) 2002-08-29
MXPA02001988A (es) 2002-08-20
SK2532002A3 (en) 2002-09-10
HUP0202842A3 (en) 2003-03-28
WO2001014393A2 (fr) 2001-03-01
EA005080B1 (ru) 2004-10-28
BR0013569B1 (pt) 2014-02-25
MEP20108A (en) 2010-06-10
CN1183151C (zh) 2005-01-05
JP2003507484A (ja) 2003-02-25
WO2001014393A3 (fr) 2001-06-21
PT1212336E (pt) 2004-04-30
ZA200201599B (en) 2003-04-30
TR200200506T2 (tr) 2002-08-21
SI1212336T1 (en) 2004-04-30
UA73523C2 (uk) 2005-08-15
ES2209970T3 (es) 2004-07-01
NO20020926D0 (no) 2002-02-26
AU774385B2 (en) 2004-06-24
NO322622B1 (no) 2006-11-06
RS50433B (sr) 2009-12-31
TWI272949B (en) 2007-02-11
DE60006976T2 (de) 2004-10-21
IL148128A0 (en) 2002-09-12
KR20020033771A (ko) 2002-05-07
HU229075B1 (hu) 2013-07-29
CN1371386A (zh) 2002-09-25
SK287588B6 (sk) 2011-03-04
ATE255590T1 (de) 2003-12-15
HK1049167B (zh) 2005-08-19
PL353137A1 (en) 2003-10-20
KR100718222B1 (ko) 2007-05-15
EP1212336B1 (de) 2003-12-03
CA2382497A1 (fr) 2001-03-01
IL148128A (en) 2006-10-31
US6825218B1 (en) 2004-11-30
FR2797875B1 (fr) 2001-10-19
CZ2002594A3 (cs) 2002-09-11
EA200200294A1 (ru) 2002-08-29
JP4871467B2 (ja) 2012-02-08
HUP0202842A2 (hu) 2003-01-28
HRP20020167A2 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
DE60210480D1 (de) Wasser absorbierendes harzpulver sowie verfahren zur herstellung und verwendung desselben
DE59401343D1 (de) Medizinisches pflastermaterial sowie verfahren zu seiner herstellung
DE69418903T2 (de) Verfahren zur herstellung wässeriger perameisensäurelösungen und deren verwendung
DE69820119D1 (de) Gelierte nahrungsmittel sowie verfahren zu deren herstellung
DE59404480D1 (de) Fullerenderivate, verfahren zur herstellung und deren verwendung
DE50002122D1 (de) Resorbierbares knochen-implantatmaterial sowie verfahren zur herstellung desselben
DE50003914D1 (de) Verfahren und vorrichtung zur herstellung von bürsten sowie danach hergestellte bürsten
DE59709239D1 (de) 7alpha-(epsilon-aminoalkyl)-estratriene, verfahren zu deren herstellung, pharmazeutische präparate, die diese 7alpha-(epsilon-aminoalkyl)-estratriene enthalten sowie deren verwendung zur herstellung von arzneimitteln
DE69706869T2 (de) Verfahren zur herstellung von ultrafeinen teilchen sowie diese hergestellte teilchen
DE60117573D1 (de) Verschiedenartig gehärtete materialen und verfahren zur deren herstellung
ATA148194A (de) Verfahren zur herstellung von wasserverdünnbaren urethanharzen und deren verwendung
DE60045480D1 (de) Druckempfindliches klebeband und verfahren zur herstellung desselben
DE69901178D1 (de) Nichtgesinterte elektrode und verfahren zur herstellung
DE60032943D1 (de) Imid-benzoxazolpolykondensat sowie verfahren zur herstellung
DE69524977T2 (de) Lösliche, elektroleitfähige polypyrrole und verfahren zur herstellung
DE59814132D1 (de) Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
DE69813312D1 (de) Verfahren zur herstellung von cyclopropylethyn sowie zwischenprodukte zur herstellung von cyclopropylethyn
DE69812365T2 (de) Enthaarungsmitteln, verfahren zur herstellung sowie ihre verwendung
DE59103061D1 (de) Verfahren zur herstellung polyolhaltiger dispersionen und deren verwendung.
DE69914057D1 (de) Nasspanadenbeschichtete pommes frittes-streifen sowie verfahren zur herstellung
ATE240126T1 (de) Verfahren zur herstellung superabsorber-polymere enthaltender körper und deren verwendung
ATE341338T1 (de) Hapten modifizierte tumorzellen und verfahren zur herstellung und deren verwendung
DE50002181D1 (de) Vorrichtung und verfahren zur herstellung von salzschmelzen und deren verwendung
DE69819513D1 (de) Hydroxylapatit verbundwerstoff verfahren zu deren herstellung sowie deren verwendung
DE60006976D1 (de) Verfahren zur herstellung von sphärische telithromycin-agglomerate sowie deren verwendung zur vorbereitung von arzneiformen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC